Press Releases

 
Press Releases
  Date Title View
Nov 17, 2016
Highlights at the end of September 30, 2016: Total cumulated revenue in 2016  up 22% year-over-year;Driven by HIFU growth, Gross Margin increases to 45%;111% growth in HIFU revenues in Q3 of 2016 compared to Q3 2015;Company continues to show operating profit in 2016 at the end of Q3;Strong cash position of EUR 18.8 million as of September 30, ...
Nov 3, 2016
LYON, France, Nov. 03, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it plans to release financial results for the third quarter ended September 30, 2016 on Thursday, November 17, 2016, during pre-market hours. Company management will host a conference call on Thursday, ...
Oct 11, 2016
LYON, France, Oct. 11, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the results of a multicentric study using Ablatherm Robotic HIFU which demonstrates promising oncologic outcomes with low side effects. The results of the study have been electronically published in the prestigio...
Sep 12, 2016
LYON, France, Sept. 12, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the signature of a contract for the installation of Ablatherm Robotic HIFU at the renowned Duke University Hospital located in Durham, North Carolina. Marc Oczachowski, EDAP TMS Chief Executive Officer, sai...
Sep 6, 2016
LYON, France, Sept. 06, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Marc Oczachowski, Chief Executive Officer of EDAP TMS, is scheduled to present at the 18th Annual Rodman & Renshaw Global Investment Conference being held September 11-13, 2016 at the Lotte New York Palace ...
Aug 25, 2016
Total EDAP revenue up 20.4% year-over-year in the first six months of 2016Continued growth in HIFU system sales and treatment-driven revenue with strong marginsFocal One® 510k under FDA reviewSolid cash position at €21.9 million as of June 30, 2016LYON, France, Aug. 25, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global le...
Aug 22, 2016
LYON, France, Aug. 22, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first prostate ablation treatments performed at Henry Ford Hospital in Detroit, Michigan, using the Company's FDA-cleared Ablatherm Robotic HIFU. This Ablatherm Robotic HIFU device is owned by HIFU Solut...
Aug 11, 2016
LYON, France, Aug. 11, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it plans to release financial results for the second quarter ended June 30, 2016 on Thursday, August 25, 2016, during pre-market hours. Company management will host a conference call on Thursday, August...
Jun 16, 2016
LYON, France, June 16, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first prostate ablation treatments performed at Radiosurgery of New York and Eastern Massachusetts Surgery Center, using the Company's FDA-cleared Ablatherm Robotic HIFU device deployed by HIFU USA Corp, a le...
Jun 14, 2016
LYON, France, June 14, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first prostate ablation treatment performed at a site managed by Allied Urological Services ("Allied"), an affiliate of Austin, Texas based HealthTronics, Inc. in New York, NY, using the Company's FDA-cleared...
1
... NextLast
= add release to Briefcase